The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Carbapenems are broad-spectrum antibiotics. That is, they are effective against many types of bacteria, including bacteria that are resistant to many other antibiotics. Carbapenems include the following: Doripenem. Ertapenem.
The global Carbapenem market was valued at US$ 3620 million in 2023 and is anticipated to reach US$ 5002.2 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
North American market for Carbapenem is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Carbapenem is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Carbapenem include Pfizer, Savior Lifetec, Sun Pharmaceutical Industries, Kopran, HISUN Pharmaceutical, Haibin Pharmaceutical and United Lab, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Carbapenem, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carbapenem.
Report Scope
The Carbapenem market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Carbapenem market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carbapenem manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Savior Lifetec
Sun Pharmaceutical Industries
Kopran
HISUN Pharmaceutical
Haibin Pharmaceutical
United Lab
Segment by Type
Meropenem
Doripenem
Imipenem
Panipenem
Others
Segment by Application
Hosptials
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Carbapenem manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Carbapenem in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Carbapenems are broad-spectrum antibiotics. That is, they are effective against many types of bacteria, including bacteria that are resistant to many other antibiotics. Carbapenems include the following: Doripenem. Ertapenem.
The global Carbapenem market was valued at US$ 3620 million in 2023 and is anticipated to reach US$ 5002.2 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
North American market for Carbapenem is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Carbapenem is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Carbapenem include Pfizer, Savior Lifetec, Sun Pharmaceutical Industries, Kopran, HISUN Pharmaceutical, Haibin Pharmaceutical and United Lab, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Carbapenem, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carbapenem.
Report Scope
The Carbapenem market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Carbapenem market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carbapenem manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Savior Lifetec
Sun Pharmaceutical Industries
Kopran
HISUN Pharmaceutical
Haibin Pharmaceutical
United Lab
Segment by Type
Meropenem
Doripenem
Imipenem
Panipenem
Others
Segment by Application
Hosptials
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Carbapenem manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Carbapenem in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Carbapenem Market Overview
1.1 Product Overview and Scope of Carbapenem
1.2 Carbapenem Segment by Type
1.2.1 Global Carbapenem Market Value Comparison by Type (2024-2030)
1.2.2 Meropenem
1.2.3 Doripenem
1.2.4 Imipenem
1.2.5 Panipenem
1.2.6 Others
1.3 Carbapenem Segment by Application
1.3.1 Global Carbapenem Market Value by Application: (2024-2030)
1.3.2 Hosptials
1.3.3 Clinics
1.3.4 Others
1.4 Global Carbapenem Market Size Estimates and Forecasts
1.4.1 Global Carbapenem Revenue 2019-2030
1.4.2 Global Carbapenem Sales 2019-2030
1.4.3 Global Carbapenem Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Carbapenem Market Competition by Manufacturers
2.1 Global Carbapenem Sales Market Share by Manufacturers (2019-2024)
2.2 Global Carbapenem Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Carbapenem Average Price by Manufacturers (2019-2024)
2.4 Global Carbapenem Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Carbapenem, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Carbapenem, Product Type & Application
2.7 Carbapenem Market Competitive Situation and Trends
2.7.1 Carbapenem Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Carbapenem Players Market Share by Revenue
2.7.3 Global Carbapenem Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Carbapenem Retrospective Market Scenario by Region
3.1 Global Carbapenem Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Carbapenem Global Carbapenem Sales by Region: 2019-2030
3.2.1 Global Carbapenem Sales by Region: 2019-2024
3.2.2 Global Carbapenem Sales by Region: 2025-2030
3.3 Global Carbapenem Global Carbapenem Revenue by Region: 2019-2030
3.3.1 Global Carbapenem Revenue by Region: 2019-2024
3.3.2 Global Carbapenem Revenue by Region: 2025-2030
3.4 North America Carbapenem Market Facts & Figures by Country
3.4.1 North America Carbapenem Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Carbapenem Sales by Country (2019-2030)
3.4.3 North America Carbapenem Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Carbapenem Market Facts & Figures by Country
3.5.1 Europe Carbapenem Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Carbapenem Sales by Country (2019-2030)
3.5.3 Europe Carbapenem Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Carbapenem Market Facts & Figures by Country
3.6.1 Asia Pacific Carbapenem Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Carbapenem Sales by Country (2019-2030)
3.6.3 Asia Pacific Carbapenem Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Carbapenem Market Facts & Figures by Country
3.7.1 Latin America Carbapenem Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Carbapenem Sales by Country (2019-2030)
3.7.3 Latin America Carbapenem Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Carbapenem Market Facts & Figures by Country
3.8.1 Middle East and Africa Carbapenem Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Carbapenem Sales by Country (2019-2030)
3.8.3 Middle East and Africa Carbapenem Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Carbapenem Sales by Type (2019-2030)
4.1.1 Global Carbapenem Sales by Type (2019-2024)
4.1.2 Global Carbapenem Sales by Type (2025-2030)
4.1.3 Global Carbapenem Sales Market Share by Type (2019-2030)
4.2 Global Carbapenem Revenue by Type (2019-2030)
4.2.1 Global Carbapenem Revenue by Type (2019-2024)
4.2.2 Global Carbapenem Revenue by Type (2025-2030)
4.2.3 Global Carbapenem Revenue Market Share by Type (2019-2030)
4.3 Global Carbapenem Price by Type (2019-2030)
5 Segment by Application
5.1 Global Carbapenem Sales by Application (2019-2030)
5.1.1 Global Carbapenem Sales by Application (2019-2024)
5.1.2 Global Carbapenem Sales by Application (2025-2030)
5.1.3 Global Carbapenem Sales Market Share by Application (2019-2030)
5.2 Global Carbapenem Revenue by Application (2019-2030)
5.2.1 Global Carbapenem Revenue by Application (2019-2024)
5.2.2 Global Carbapenem Revenue by Application (2025-2030)
5.2.3 Global Carbapenem Revenue Market Share by Application (2019-2030)
5.3 Global Carbapenem Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Carbapenem Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Carbapenem Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Savior Lifetec
6.2.1 Savior Lifetec Corporation Information
6.2.2 Savior Lifetec Description and Business Overview
6.2.3 Savior Lifetec Carbapenem Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Savior Lifetec Carbapenem Product Portfolio
6.2.5 Savior Lifetec Recent Developments/Updates
6.3 Sun Pharmaceutical Industries
6.3.1 Sun Pharmaceutical Industries Corporation Information
6.3.2 Sun Pharmaceutical Industries Description and Business Overview
6.3.3 Sun Pharmaceutical Industries Carbapenem Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sun Pharmaceutical Industries Carbapenem Product Portfolio
6.3.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.4 Kopran
6.4.1 Kopran Corporation Information
6.4.2 Kopran Description and Business Overview
6.4.3 Kopran Carbapenem Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Kopran Carbapenem Product Portfolio
6.4.5 Kopran Recent Developments/Updates
6.5 HISUN Pharmaceutical
6.5.1 HISUN Pharmaceutical Corporation Information
6.5.2 HISUN Pharmaceutical Description and Business Overview
6.5.3 HISUN Pharmaceutical Carbapenem Sales, Revenue and Gross Margin (2019-2024)
6.5.4 HISUN Pharmaceutical Carbapenem Product Portfolio
6.5.5 HISUN Pharmaceutical Recent Developments/Updates
6.6 Haibin Pharmaceutical
6.6.1 Haibin Pharmaceutical Corporation Information
6.6.2 Haibin Pharmaceutical Description and Business Overview
6.6.3 Haibin Pharmaceutical Carbapenem Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Haibin Pharmaceutical Carbapenem Product Portfolio
6.6.5 Haibin Pharmaceutical Recent Developments/Updates
6.7 United Lab
6.6.1 United Lab Corporation Information
6.6.2 United Lab Description and Business Overview
6.6.3 United Lab Carbapenem Sales, Revenue and Gross Margin (2019-2024)
6.4.4 United Lab Carbapenem Product Portfolio
6.7.5 United Lab Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Carbapenem Industry Chain Analysis
7.2 Carbapenem Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Carbapenem Production Mode & Process
7.4 Carbapenem Sales and Marketing
7.4.1 Carbapenem Sales Channels
7.4.2 Carbapenem Distributors
7.5 Carbapenem Customers
8 Carbapenem Market Dynamics
8.1 Carbapenem Industry Trends
8.2 Carbapenem Market Drivers
8.3 Carbapenem Market Challenges
8.4 Carbapenem Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Carbapenem Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Carbapenem Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Carbapenem Market Competitive Situation by Manufacturers in 2023
Table 4. Global Carbapenem Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Carbapenem Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Carbapenem Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Carbapenem Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Carbapenem Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Carbapenem, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Carbapenem, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Carbapenem, Product Type & Application
Table 12. Global Key Manufacturers of Carbapenem, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Carbapenem by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carbapenem as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Carbapenem Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Carbapenem Sales by Region (2019-2024) & (K Units)
Table 18. Global Carbapenem Sales Market Share by Region (2019-2024)
Table 19. Global Carbapenem Sales by Region (2025-2030) & (K Units)
Table 20. Global Carbapenem Sales Market Share by Region (2025-2030)
Table 21. Global Carbapenem Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Carbapenem Revenue Market Share by Region (2019-2024)
Table 23. Global Carbapenem Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Carbapenem Revenue Market Share by Region (2025-2030)
Table 25. North America Carbapenem Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Carbapenem Sales by Country (2019-2024) & (K Units)
Table 27. North America Carbapenem Sales by Country (2025-2030) & (K Units)
Table 28. North America Carbapenem Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Carbapenem Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Carbapenem Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Carbapenem Sales by Country (2019-2024) & (K Units)
Table 32. Europe Carbapenem Sales by Country (2025-2030) & (K Units)
Table 33. Europe Carbapenem Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Carbapenem Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Carbapenem Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Carbapenem Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Carbapenem Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Carbapenem Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Carbapenem Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Carbapenem Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Carbapenem Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Carbapenem Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Carbapenem Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Carbapenem Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Carbapenem Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Carbapenem Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Carbapenem Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Carbapenem Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Carbapenem Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Carbapenem Sales (K Units) by Type (2019-2024)
Table 51. Global Carbapenem Sales (K Units) by Type (2025-2030)
Table 52. Global Carbapenem Sales Market Share by Type (2019-2024)
Table 53. Global Carbapenem Sales Market Share by Type (2025-2030)
Table 54. Global Carbapenem Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Carbapenem Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Carbapenem Revenue Market Share by Type (2019-2024)
Table 57. Global Carbapenem Revenue Market Share by Type (2025-2030)
Table 58. Global Carbapenem Price (USD/Unit) by Type (2019-2024)
Table 59. Global Carbapenem Price (USD/Unit) by Type (2025-2030)
Table 60. Global Carbapenem Sales (K Units) by Application (2019-2024)
Table 61. Global Carbapenem Sales (K Units) by Application (2025-2030)
Table 62. Global Carbapenem Sales Market Share by Application (2019-2024)
Table 63. Global Carbapenem Sales Market Share by Application (2025-2030)
Table 64. Global Carbapenem Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Carbapenem Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Carbapenem Revenue Market Share by Application (2019-2024)
Table 67. Global Carbapenem Revenue Market Share by Application (2025-2030)
Table 68. Global Carbapenem Price (USD/Unit) by Application (2019-2024)
Table 69. Global Carbapenem Price (USD/Unit) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Carbapenem Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Carbapenem Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Savior Lifetec Corporation Information
Table 76. Savior Lifetec Description and Business Overview
Table 77. Savior Lifetec Carbapenem Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Savior Lifetec Carbapenem Product
Table 79. Savior Lifetec Recent Developments/Updates
Table 80. Sun Pharmaceutical Industries Corporation Information
Table 81. Sun Pharmaceutical Industries Description and Business Overview
Table 82. Sun Pharmaceutical Industries Carbapenem Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Sun Pharmaceutical Industries Carbapenem Product
Table 84. Sun Pharmaceutical Industries Recent Developments/Updates
Table 85. Kopran Corporation Information
Table 86. Kopran Description and Business Overview
Table 87. Kopran Carbapenem Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Kopran Carbapenem Product
Table 89. Kopran Recent Developments/Updates
Table 90. HISUN Pharmaceutical Corporation Information
Table 91. HISUN Pharmaceutical Description and Business Overview
Table 92. HISUN Pharmaceutical Carbapenem Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. HISUN Pharmaceutical Carbapenem Product
Table 94. HISUN Pharmaceutical Recent Developments/Updates
Table 95. Haibin Pharmaceutical Corporation Information
Table 96. Haibin Pharmaceutical Description and Business Overview
Table 97. Haibin Pharmaceutical Carbapenem Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Haibin Pharmaceutical Carbapenem Product
Table 99. Haibin Pharmaceutical Recent Developments/Updates
Table 100. United Lab Corporation Information
Table 101. United Lab Description and Business Overview
Table 102. United Lab Carbapenem Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. United Lab Carbapenem Product
Table 104. United Lab Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Carbapenem Distributors List
Table 108. Carbapenem Customers List
Table 109. Carbapenem Market Trends
Table 110. Carbapenem Market Drivers
Table 111. Carbapenem Market Challenges
Table 112. Carbapenem Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Carbapenem
Figure 2. Global Carbapenem Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Carbapenem Market Share by Type in 2023 & 2030
Figure 4. Meropenem Product Picture
Figure 5. Doripenem Product Picture
Figure 6. Imipenem Product Picture
Figure 7. Panipenem Product Picture
Figure 8. Others Product Picture
Figure 9. Global Carbapenem Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Carbapenem Market Share by Application in 2023 & 2030
Figure 11. Hosptials
Figure 12. Clinics
Figure 13. Others
Figure 14. Global Carbapenem Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Carbapenem Market Size (2019-2030) & (US$ Million)
Figure 16. Global Carbapenem Sales (2019-2030) & (K Units)
Figure 17. Global Carbapenem Average Price (USD/Unit) & (2019-2030)
Figure 18. Carbapenem Report Years Considered
Figure 19. Carbapenem Sales Share by Manufacturers in 2023
Figure 20. Global Carbapenem Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Carbapenem Players: Market Share by Revenue in 2023
Figure 22. Carbapenem Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Carbapenem Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Carbapenem Sales Market Share by Country (2019-2030)
Figure 25. North America Carbapenem Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Carbapenem Sales Market Share by Country (2019-2030)
Figure 29. Europe Carbapenem Revenue Market Share by Country (2019-2030)
Figure 30. Germany Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Carbapenem Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Carbapenem Revenue Market Share by Region (2019-2030)
Figure 37. China Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Carbapenem Sales Market Share by Country (2019-2030)
Figure 48. Latin America Carbapenem Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Carbapenem Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Carbapenem Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. U.A.E Carbapenem Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Carbapenem by Type (2019-2030)
Figure 58. Global Revenue Market Share of Carbapenem by Type (2019-2030)
Figure 59. Global Carbapenem Price (USD/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of Carbapenem by Application (2019-2030)
Figure 61. Global Revenue Market Share of Carbapenem by Application (2019-2030)
Figure 62. Global Carbapenem Price (USD/Unit) by Application (2019-2030)
Figure 63. Carbapenem Value Chain
Figure 64. Carbapenem Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
